Oregon is expanding access to hepatitis C drugs
Clip: 05/23/2018 | 8m 30s
New drugs can cure up to 95 percent of patients with hepatitis C, a virus that can be debilitating or deadly. And there’s been a 20 percent rise in new infections from 2015 to 2016 due to the opioid epidemic. In Oregon, a state hard-hit by the disease, new medicines combined with the big surge in those looking for treatment has led to a unique care model. Special correspondent Cat Wise reports.
Aired: 05/23/18Video has closed captioning.
Problems Playing Video?
Major corporate funding for the PBS NewsHour is provided by BNSF, Consumer Cellular, Leidos, Babbel, and Raymond James. Funding for the PBS NewsHour Weekend is provided by Mutual of America. For a complete list of funders for the PBS NewsHour and PBS NewsHour weekend, click here.